| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 8,460 | $40 | $321.5K |
| J9271 | Injection, pembrolizumab, 1 mg | 5,200 | $40 | $223.6K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,840 | $20 | $40.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 370 | $110 | $38.9K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 260 | $130 | $34.3K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 190 | $90 | $17K |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community… | 80 | $210 | $15.6K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 110 | $140 | $15.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 200 | $70 | $13.2K |
| J0185 | Injection, aprepitant, 1 mg | 13,000 | $1 | $13K |